Jose P. Zevallos
Experienced in Hyperparathyroidism

Dr. Jose P. Zevallos

Otolaryngology
UPMC
Univ. Ear Nose & Throat Specialists - Eye And Ear Inst.
203 Lothrop Street, Suite 300, 
Pittsburgh, PA 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Experienced in Hyperparathyroidism
UPMC
Univ. Ear Nose & Throat Specialists - Eye And Ear Inst.
203 Lothrop Street, Suite 300, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

José P. Zevallos, MD, MPH, is the Eugene N. Myers, M.D. Chairman of Otolaryngology at the University of Pittsburgh Medical Center (UPMC).  Dr. Zevallos received his medical degree from Rutgers University and completed his residency at Baylor College of Medicine in Houston, Texas. From there, he went on to do a fellowship in Head and Neck Oncology and Microvascular Reconstruction at Beth Israel Mount Sinai Hospital in New York City.  Prior to this position, he served as Division Chief of Head and Neck Surgery at Washington University School of Medicine and the Siteman Cancer Center in St. Louis, Missouri.

Dr. Zevallos is rated as an Experienced provider by MediFind in the treatment of Hyperparathyroidism. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Laryngectomy, and Thyroidectomy.

His clinical research consists of co-authoring 158 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Rutgers New Jersey Medical School
Residency
Baylor College of Medicine
Specialties
Otolaryngology
Licenses
Otolaryngology in MO
Board Certifications
American Board Of Otolaryngology - Head And Neck Surgery
Fellowships
Mount Sinai Beth Israel
Hospital Affiliations
Upmc Presbyterian Shadyside
Barnes Jewish Hospital
Languages Spoken
English
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 4 Less Insurance Carriers -

Locations

Univ. Ear Nose & Throat Specialists - Eye and Ear Inst.
203 Lothrop Street, Suite 300, Pittsburgh, PA 15213
Call: 412-647-2100
Other Locations
University Ear, Nose & Throat Specialists at UPMC Shadyside
5200 Centre Avenue, Suite 211, Pittsburgh, PA 15232
Call: 412-621-0123

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Non-Randomized Phase 2 Trial of Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma
Non-Randomized Phase 2 Trial of Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma
Enrollment Status: Recruiting
Publish Date: February 06, 2025
Intervention Type: Drug
Study Drug: CUE-101
Study Phase: Phase 2
Phase II Trial of Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: The Minimalist Trial (MINT)
Phase II Trial of Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: The Minimalist Trial (MINT)
Enrollment Status: Active_not_recruiting
Publish Date: August 17, 2025
Intervention Type: Other, Drug, Radiation, Procedure
Study Drug: Cisplatin
Study Phase: Phase 2
Los Tres Paso Trial: Step One - Neoadjuvant Palbociclib Monotherapy, Step Two - Concurrent Chemoradiation Therapy, and Step Three - Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma
Los Tres Paso Trial: Step One - Neoadjuvant Palbociclib Monotherapy, Step Two - Concurrent Chemoradiation Therapy, and Step Three - Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2025
Intervention Type: Drug, Procedure, Radiation
Study Drugs: Palbociclib, Cetuximab, Cisplatin
Study Phase: Phase 2
Phase II Non-Randomized Three Arm Trial of Induction Chemotherapy With Nab-Paclitaxel and Cisplatin (AP: Arms 1 and 3) or Single Agent Nab-paclitaxel (A: Arm 2) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC): The APA Trial.
Phase II Non-Randomized Three Arm Trial of Induction Chemotherapy With Nab-Paclitaxel and Cisplatin (AP: Arms 1 and 3) or Single Agent Nab-paclitaxel (A: Arm 2) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC): The APA Trial.
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug, Radiation, Biological
Study Drugs: Nab-Paclitaxel, Cisplatin, Cetuximab
Study Phase: Phase 2
Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT
Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Prospective Phase I and II Trial of Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy
A Prospective Phase I and II Trial of Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy
Enrollment Status: Terminated
Publish Date: December 03, 2020
Intervention Type: Procedure, Drug, Other
Study Phase: Phase 1/Phase 2
View 5 Less Clinical Trials

158 Total Publications

Trends in the Use of Neoadjuvant Systemic Therapy for Head and Neck Squamous Cell Carcinoma.
Trends in the Use of Neoadjuvant Systemic Therapy for Head and Neck Squamous Cell Carcinoma.
Journal: JAMA network open
Published: October 28, 2025
View All 158 Publications
Similar Doctors
Advanced in Hyperparathyroidism
Dr. David P. Demarino
Otolaryngology
Advanced in Hyperparathyroidism
Dr. David P. Demarino
Otolaryngology

South Hills Ent Association

2000 Oxford Dr, Suite 201, 
Bethel Park, PA 
 (8.6 miles away)
412-831-7570
Languages Spoken:
English
See accepted insurances

David Demarino is an Otolaryngologist in Bethel Park, Pennsylvania. Dr. Demarino is rated as a Distinguished provider by MediFind in the treatment of Hyperparathyroidism. His top areas of expertise are Perichondritis, Laryngitis, Infant Hearing Loss, and DFNB1.

Paul Dibiase
Advanced in Hyperparathyroidism
Dr. Paul Dibiase
Otolaryngology
Advanced in Hyperparathyroidism
Dr. Paul Dibiase
Otolaryngology

Trinity Professional Group (Mastros DiBiase Office)

2315 Sunset Blvd, Suite A, 
Steubenville, OH 
 (36.6 miles away)
740-266-7006
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Notes: To refer a patient or consult with Dr. DiBiase, please call (740) 266-7006.Specialty:OtolaryngologyThyroid and parathyroid tumorsTumors of the pharynx, larynx, nose, and paranasal sinusesMelanoma and skin cancers of the head, neck, and faceNasal obstructionMouth or tongue lesionsEar fullness or clogged sensationNeck masses involving facial masses, lymph nodes, or glandsRecurrent or chronic sinusitisPost nasal dischargeRecurrent throat infectionsEar discharge or infectionsSudden hearing lossAesthetic surgery of the nose (rhinoplasty) and complicated revisionSurgical correction of facial nerve injuriesRestoration of facial contour after injuryPediatric Head & Neck SurgeryAudiologySpeech TherapyInternship: General Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA. Dr. Dibiase is rated as an Advanced provider by MediFind in the treatment of Hyperparathyroidism. His top areas of expertise are Thyroid Nodule, Sinusitis, Hyperparathyroidism, and Infant Hearing Loss.

Advanced in Hyperparathyroidism
Dr. Bosco E. Noronha
Otolaryngology
Advanced in Hyperparathyroidism
Dr. Bosco E. Noronha
Otolaryngology

Bosco E Noronha Md,pc

1265 Wayne Ave, Suite 100, 
Indiana, PA 
 (43.1 miles away)
724-349-5440
Languages Spoken:
English
See accepted insurances

Bosco Noronha is an Otolaryngologist in Indiana, Pennsylvania. Dr. Noronha is rated as a Distinguished provider by MediFind in the treatment of Hyperparathyroidism. His top areas of expertise are Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Empyema, Infant Hearing Loss, Sinusitis, and Myringotomy.

VIEW MORE HYPERPARATHYROIDISM DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Zevallos's expertise for a condition
ConditionClose
  • Elite
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
    Dr. Zevallos is
    Elite
    . Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
    See more Head and Neck Squamous Cell Carcinoma (HNSCC) experts
  • Laryngeal Cancer
    Dr. Zevallos is
    Elite
    . Learn about Laryngeal Cancer.
    See more Laryngeal Cancer experts
  • Throat Cancer
    Dr. Zevallos is
    Elite
    . Learn about Throat Cancer.
    See more Throat Cancer experts
  • Distinguished
  • Human Papillomavirus Infection
    Dr. Zevallos is
    Distinguished
    . Learn about Human Papillomavirus Infection.
    See more Human Papillomavirus Infection experts
  • Tongue Cancer
    Dr. Zevallos is
    Distinguished
    . Learn about Tongue Cancer.
    See more Tongue Cancer experts
  • Advanced
  • Laryngectomy
    Dr. Zevallos is
    Advanced
    . Learn about Laryngectomy.
    See more Laryngectomy experts
  • Papillary Thyroid Cancer
    Dr. Zevallos is
    Advanced
    . Learn about Papillary Thyroid Cancer.
    See more Papillary Thyroid Cancer experts
  • Thyroid Cancer
    Dr. Zevallos is
    Advanced
    . Learn about Thyroid Cancer.
    See more Thyroid Cancer experts
  • Experienced
  • Acinic Cell Carcinoma of Salivary Glands
    Dr. Zevallos is
    Experienced
    . Learn about Acinic Cell Carcinoma of Salivary Glands.
    See more Acinic Cell Carcinoma of Salivary Glands experts
  • Adenoid Cystic Carcinoma
    Dr. Zevallos is
    Experienced
    . Learn about Adenoid Cystic Carcinoma.
    See more Adenoid Cystic Carcinoma experts
  • Anaplastic Thyroid Cancer
    Dr. Zevallos is
    Experienced
    . Learn about Anaplastic Thyroid Cancer.
    See more Anaplastic Thyroid Cancer experts
  • Aseptic and Alopecic Nodules of Scalp (AANS)
    Dr. Zevallos is
    Experienced
    . Learn about Aseptic and Alopecic Nodules of Scalp (AANS).
    See more Aseptic and Alopecic Nodules of Scalp (AANS) experts
  • Ewing Sarcoma
    Dr. Zevallos is
    Experienced
    . Learn about Ewing Sarcoma.
    See more Ewing Sarcoma experts
  • Familial Isolated Hyperparathyroidism
    Dr. Zevallos is
    Experienced
    . Learn about Familial Isolated Hyperparathyroidism.
    See more Familial Isolated Hyperparathyroidism experts
View All 32 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.